SFM
GSK icon

Systematic Financial Management’s GSK GSK Stock Holding History

Systematic Financial Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-17,760
Closed -$841K – 515
2020
Q1 		$841K Sell
17,760
-3,280
-16% -$175K 0.05% 153
2019
Q4 		$1.24M Sell
21,040
-8,960
-30% -$498K 0.05% 157
2019
Q3 		$1.6M Buy
30,000
+14,640
+95% +$753K 0.07% 151
2019
Q2 		$768K Sell
15,360
-1,040
-6% -$52.2K 0.03% 468
2019
Q1 		$857K Hold
16,400
– – 0.03% 533
2018
Q4 		$783K Hold
16,400
– – 0.02% 539
2018
Q3 		$823K Buy
+16,400
New +$833K 0.02% 581

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Systematic Financial Management's GSK Position: Q2 2020 in Review

Systematic Financial Management sold out of GSK (GSK) in Q2 2020, closing a stake of 17,760 shares — an estimated $841K sold.

Systematic Financial Management first reported a position in GSK in Q3 2018 and held it in 7 quarters. The position peaked at $1.6M in Q3 2019. 840 funds tracked by Wall St. Rank hold GSK as of Q2 2020.

  • Systematic Financial Management reported no remaining GSK position as of Q2 2020 after selling out during the quarter.
  • Systematic Financial Management sold 17,760 GSK shares in Q2 2020, an estimated $841K.
  • Systematic Financial Management first reported a position in GSK in Q3 2018 and held it in 7 quarters.
  • Systematic Financial Management's GSK position peaked at $1.6M in Q3 2019.
  • 840 funds tracked by Wall St. Rank held GSK as of Q2 2020.

Based on Systematic Financial Management's 13F filing for Q2 2020, filed 13 Aug 2020.